Antiemetic Strategies in Patients Who Undergo Hematopoietic Stem Cell Transplantation

Hematopoietic stem cell transplantation (HSCT) is an integral part of the treatment strategy in patients with a hematological disorder. Chemotherapy-induced nausea and vomiting (CINV) is still an issue in patients who undergo HSCT. While several guidelines for the antiemetic therapy against CINV hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuda, Sayako, Fuji, Shigeo, Savani, Bipin, Gatwood, Katie S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492824/
https://www.ncbi.nlm.nih.gov/pubmed/36131129
http://dx.doi.org/10.1007/s44228-022-00012-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492824/
https://www.ncbi.nlm.nih.gov/pubmed/36131129
http://dx.doi.org/10.1007/s44228-022-00012-8

Ejemplares similares